All News

Implementing HPV Self-Collection Tests in Primary Care: A Discussion with Ada Stewart, MD
September 12, 2025

Ada Stewart, MD, board-certified family physician, offers strategies for introducing HPV self-collection tests, addressing patient communication, follow-up challenges, and more.

Duration of Use Guidance Published for Systemic Corticosteroids in Atopic Dermatitis Treatment
September 12, 2025

The new position paper faults the absence of a clearly defined, evidence-based ceiling on duration of use for the persistent overuse of systemic corticosteroids for AD management.

Rideshare Program Could Improve Colonoscopy Completion and Reduce CRC Burden, Study Finds
September 12, 2025

A new modeling study suggests rideshare programs could double colonoscopy completion after abnormal FIT results, cutting colorectal cancer incidence and deaths while saving health care costs.

New FDA Guidance Seeks to Expand Nonopioid Options to Manage Chronic Pain and Curb Misuse
September 12, 2025

Opioids are still prescribed to 1 in 5 US adults with chronic pain because effective alternatives are not available; the FDA guidance supports enhanced research paradigms.

Subcutaneous Leqembi Autoinjector Gains FDA Approval for Maintenance Use in Early Alzheimer Disease: Daily Dose
September 12, 2025

Your daily dose of the clinical news you may have missed.

Family Physician Teresa Lovins, MD, Says A Simple Phone Call Could Save a Life
September 11, 2025

The phone call can be short, but the outreach and contact are key after a patient with suicidal ideation is referred for emergency or inpatient support, Lovins says.

HPV Self-Collection: A New Tool for Cervical Cancer Screening in Primary Care
September 11, 2025

Ada Stewart, MD, discusses how HPV self-collection tests can expand cervical cancer screening options in primary care while addressing patient barriers and limitations.

Oral Blarcamesine Shows Marked Reduction in Cognitive Decline in Early Alzheimer Disease: Phase 2b/3 Data
September 11, 2025

Once-daily blarcamesine was associated with minimal cognitive decline at 48 weeks, with changes comparable to those observed in prodromal aging.

Merck's 21-Valent Pneumococcal Vaccine Shows Positive Immune Response in At-Risk Children, Adolescents
September 11, 2025

Merck's CAPVAXIVE could cover approximately 78% of invasive pneumococcal disease cases in youth with chronic health conditions, vs other approved pneumococcal conjugate vaccines.

New Data Shows Risk of Major Depressive Disorder Spikes After a Medical Diagnosis: Daily Dose
September 11, 2025

Your daily dose of the clinical news you may have missed.